Envoy Medical, Inc.
COCH
$1.38
$0.010.73%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.35% | 38.53% | 38.79% | 33.33% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.35% | 38.53% | 38.79% | 33.33% | -- |
| Cost of Revenue | 20.97% | 38.22% | 13.54% | 10.47% | -- |
| Gross Profit | -24.08% | -38.03% | -1.15% | 1.55% | -- |
| SG&A Expenses | 50.94% | 55.30% | 111.15% | 157.69% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.09% | 53.22% | 81.92% | 108.96% | -- |
| Operating Income | -47.62% | -53.46% | -82.79% | -111.02% | -- |
| Income Before Tax | 42.17% | 65.57% | 16.37% | -87.26% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.17% | 65.57% | 16.37% | -87.26% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.17% | 65.57% | 16.37% | -87.26% | -- |
| EBIT | -47.62% | -53.46% | -82.79% | -111.02% | -- |
| EBITDA | -47.56% | -53.51% | -83.00% | -111.31% | -- |
| EPS Basic | 64.58% | 80.06% | 29.98% | -110.88% | -- |
| Normalized Basic EPS | 83.80% | 81.38% | -59.50% | -170.40% | -- |
| EPS Diluted | 64.64% | 79.84% | 29.65% | -111.61% | -- |
| Normalized Diluted EPS | 83.60% | 82.67% | -56.46% | -165.45% | -- |
| Average Basic Shares Outstanding | 93.60% | 70.81% | -64.79% | -83.18% | -- |
| Average Diluted Shares Outstanding | 88.94% | 73.29% | -64.20% | -82.85% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
